about
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well...
Read More
4.23
0.06
(1.44%)
4.9M
XNAS Volume
XNAS 18 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Annexon Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..